Thus, genetically engineered models recapitulating TP53 and PTEN deletions, as well as PI3K/AKT/mTOR activation, might be helpful as additional tools for the study of angiosarcoma development [22], although chemically induced models rather reflect the origin of carcinogenesis in humans. The gene discussed is MTOR; the disease is angiosarcoma.